ParaGard Lawsuit Consolidation To Be Considered By MDL Panel

A panel of federal judges will hear oral arguments in December over whether to consolidate and centralize all ParaGard IUD lawsuits filed throughout the federal court system before one U.S. District Judge for coordinated discovery and pretrial proceedings.

ParaGard is a copper intrauterine device (IUD), which is implanted into the uterus to provide long-term birth control up to 10 years. It involves a T-shaped plastic frame wrapped in copper wire coils, which is designed to produce an inflammatory reaction in the uterus that is toxic to sperm and prevents pregnancy.

While Paragard is intended to be easily removable and allow women to conceive after it is explanted, dozens of lawsuits are now being filed by women who indicate that the IUD broke during explant procedures, causing severe internal injuries and often resulting in the need for a total hysterectomy or other invasive surgical procedures that impact their ability to have children in the future.

Learn More About

Paragard IUD Lawsuits

Women have reported problems where Paragard IUD fractured or broken during removal, resulting in serious injury.

There are currently at least 55 complaints involving problems with Paragard pending in 29 different U.S. District Courts nationwide, each involving nearly identical allegations that the copper IUD is unreasonably dangerous and defective, since it is prone to fracturing during removal in some cases.

Last month, plaintiffs filed a motion to transfer all Paragard lawsuits, calling for all of the federal litigation to be centralized in the U.S. District Court for the Central District of California to avoid conflicting pretrial rulings from different courts, avoid duplicative discovery and serve the convenience of common witnesses, parties and the judicial system.

In an October 22 notice of hearing session (PDF), the U.S. Judicial Panel on Multidistrict Litigation (JPML) announced it will hear oral arguments over consolidation of the ParaGard lawsuits on December 3 at the Thurgood Marshall Federal Judiciary Building in Washington, DC. The hearing will be conducted by videoconference or teleconference, to follow current social distancing guidelines during the ongoing COVID-19 pandemic.

In complex product liability litigation, where a large number of claims are filed throughout the federal court system by individuals who suffered similar injuries as a result of the same or similar products or venues, it is common for the federal court system to centralize the litigation for pretrial proceedings. However, if Paragard settlements are not reached during discovery or following a series of early “bellwether” trials, each claim may later be remanded back to the U.S. District Court where it was originally filed to go before a jury.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.